Stevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS fell 25.0%, free cash flow fell 167.0% and total debt rose 9.27%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for five, operating cash flow growth for three.
Follow STVN
Stevanato Group S.p.A. (STVN) P/E ratio
As of 16 October 2026, Stevanato Group S.p.A. (STVN) trades at a P/E ratio of 33.8×. Over the past ten years it has ranged from 22.9× (April 2026) to 61.2× (August 2023); the current reading is higher than 27% of that period. That is in line with the Medical Instruments & Supplies industry median of 33.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 34.7× | (23.58%) |
| FY2024 | 45.4× | 0.80% |
| FY2023 | 45.0× | 44.19% |
| FY2022 | 31.2× | (11.91%) |
| FY2021 | 35.5× | (7.50%) |
| FY2020 | 38.3× | 0.00% |
| FY2019 | 38.3× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 32.3× | 38.46% |
| Mar 2026 | 23.3× | (32.82%) |
| Dec 2025 | 34.7× | (23.21%) |
| Sep 2025 | 45.2× | (0.14%) |
| 21 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| BLCO Bausch + Lomb Corporation compare | n/m |
| TFX Teleflex Incorporated compare | n/m |
| ATR AptarGroup, Inc. compare | 22.2× |
| STVN Stevanato Group S.p.A. | 33.8× |
| MMSI Merit Medical Systems, Inc. compare | 36.4× |
| NVST Envista Holdings Corporation compare | 38.8× |
| ICUI ICU Medical, Inc. compare | 136× |
| WRBY Warby Parker Inc. compare | 334× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)